The Diet Gout Trial
NCT03569020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2021-03-30
Summary
Unhealthy diet has long been associated with high uric acid levels and gout. The DASH diet may lower uric acid levels. This study will examine the effects of the DASH diet on uric acid in adults with a history of gout.
Conditions
- Gout
- Hyperuricemia
Interventions
- OTHER
-
Subsidy for food purchases and dietitian education
$105/wk of DASH-like foods over 4 weeks purchased with the help of a dietitian in a proportion that reflects the DASH diet.
Sponsors & Collaborators
-
Massachusetts General Hospital
collaborator OTHER -
Beth Israel Deaconess Medical Center
collaborator OTHER -
Harvard Medical School (HMS and HSDM)
collaborator OTHER -
Rheumatology Research Foundation
collaborator OTHER - lead OTHER
Principal Investigators
-
Edgar Miller · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-07
- Primary Completion
- 2019-07-23
- Completion
- 2019-07-23
Countries
- United States
Study Locations
More Related Trials
-
Gout Self-Monitoring Aiming to Reach Target
NCT03274063 ·Status: COMPLETED ·Phase: NA
-
The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout
NCT03306758 ·Status: UNKNOWN ·Phase: NA
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
Center of Research Translation (CORT) Project 2
NCT02038179 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
NCT04875702 ·Status: RECRUITING ·Phase: PHASE4
-
Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
NCT05665699 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Prednisolone Versus Colchicine for Acute Gout in Primary Care
NCT05698680 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
NCT00741442 ·Status: COMPLETED ·Phase: PHASE2
-
Gout in the ED and Improving Research Participation
NCT04075903 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
NCT00080210 ·Status: COMPLETED ·Phase: PHASE2
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
NCT06622603 ·Status: RECRUITING ·Phase: PHASE4
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
NCT01701622 ·Status: TERMINATED ·Phase: NA
-
Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients
NCT05504083 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant
NCT04087720 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Dotinurad Versus Allopurinol in Participants With Gout
NCT07089875 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Febuxostat on Blood Pressure
NCT01496469 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
RDEA3170 Monotherapy in Subjects With Gout
NCT01927198 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04052932 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
NCT01654276 ·Status: COMPLETED ·Phase: PHASE4